|
WAC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.86110049383137E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.40170122573136E-11 |
| Normal-vs-Stage2 |
1.37619999951433E-07 |
| Normal-vs-Stage3 |
5.199400E-03 |
| Normal-vs-Stage4 |
1.946550E-01 |
| Stage1-vs-Stage2 |
9.951400E-01 |
| Stage1-vs-Stage3 |
1.947640E-01 |
| Stage1-vs-Stage4 |
1.921820E-01 |
| Stage2-vs-Stage3 |
2.309400E-01 |
| Stage2-vs-Stage4 |
2.319200E-01 |
| Stage3-vs-Stage4 |
6.729000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.1896041363666E-11 |
| Normal-vs-AfricanAmerican |
1.47750000012437E-07 |
| Normal-vs-Asian |
2.113200E-01 |
| Caucasian-vs-AfricanAmerican |
8.299400E-01 |
| Caucasian-vs-Asian |
5.827200E-01 |
| AfricanAmerican-vs-Asian |
6.075400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.15516493540235E-12 |
| Normal-vs-Female |
7.061000E-03 |
| Male-vs-Female |
3.063200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.60228999999124E-05 |
| Normal-vs-Extreme_Weight |
6.33793018067763E-12 |
| Normal-vs-Obese |
5.61089999999709E-05 |
| Normal-vs-Extreme_Obese |
3.26710000053687E-07 |
| Normal_Weight-vs-Extreme_Weight |
4.257800E-01 |
| Normal_Weight-vs-Obese |
2.066000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.538400E-01 |
| Extreme_Weight-vs-Obese |
1.224010E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.894800E-01 |
| Obese-vs-Extreme_Obese |
9.444200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.661700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.92199999996079E-06 |
| Normal-vs-Age(61-80Yrs) |
2.61457522299224E-13 |
| Normal-vs-Age(81-100Yrs) |
4.45439999999797E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.298000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.051700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.918300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.420700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.435800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.795600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.57167637080147E-12 |
| Normal-VS-Type2 PRCC |
1.51339999976408E-07 |
| Normal-VS-KIRP CIMP |
1.763960E-01 |
| Normal-VS-Unclassified PRCC |
2.799800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.354600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.270100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.881980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.016850E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.652600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.022600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.82449960589781E-10 |
| Normal-vs-N1 |
2.496400E-01 |
| Normal-vs-N2 |
2.516600E-01 |
| N0-vs-N1 |
9.919500E-03 |
| N0-vs-N2 |
4.373000E-01 |
| N1-vs-N2 |
5.369400E-01 |
|
|
